Dr. Wright is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3402 W Dr Martin Luther King Jr Blvd
Tampa, FL 33607Phone+1 813-875-3950Fax+1 813-872-2741
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 1999 - 2002
- University of South Florida MorsaniResidency, Internal Medicine, 1996 - 1999
- University of South Florida College of MedicineClass of 1996
Certifications & Licensure
- FL State Medical License 1998 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
- Top MD Consumers Checkbook
Clinical Trials
- Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
Publications & Presentations
PubMed
- 5 citationsRegorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety...Andrew S. Kennedy, Dianna Shipley, Max Shpak, Laura Blakely, Brian Hemphill
Frontiers in Oncology. 2019-07-10 - 27 citationsA phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl...Khaldoun Almhanna, David Wright, Teresa Macarulla Mercade, Jean-Luc Van Laethem, Antonio Cubillo Gracian
Investigational New Drugs. 2017-05-19 - 18 citationsPhase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction exp...Khaldoun Almhanna, Maria Luisa Limon Miron, David Wright, Antonio Cubillo Gracian, Richard A. Hubner
Investigational New Drugs. 2017-02-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: